10/2/2013 7:35:57 AM
Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that Jonathan Drachman, M.D., has been promoted to Chief Medical Officer and Executive Vice President, Research and Development. Dr. Drachman joined Seattle Genetics in November 2004, serving most recently as Senior Vice President, Research and Translational Medicine. In this new role, he will lead the company’s clinical development and regulatory affairs teams, in addition to his continued oversight of research and translational medicine.
Help employers find you! Check out all the jobs and post your resume.
comments powered by